7th PREDiCT: Tumour Models London

Start Date : December 4, 2018
End Date : December 6, 2018
Time : 8:00 am to5:00 pm

Phone : 4402031418700
Email : info@hansonwade.com

Location :
Park Plaza London Riverbank, 18 Albert Embankment, Greater London, SE1 7TJ, United Kingdom

Website

Get Direction View Large Map

Description

ABOUT THE EVENT:

The PREDiCT Conference Series is dedicated to exploring the latest advances in the application of preclinical models to help us fail faster and get better disease modifying therapies from bench to patient.

 

Tumour Models London sits at the interface of innovation in model development and therapeutic application.

 

For the last 7 years it has, and will continue to, bring together a multidisciplinary mix of model developers, translational and pharmacology research scientists to debate how these tools should be further adapted to add immediate value to oncology and IO programmes.

 

WHY ATTEND? 

 

Merging its unique strategic focus and scientific quality of presentations, the event facilitates an environment of knowledge sharing and debate.

Where other conferences require you sit and listen quietly, we’ve redesigned the meeting format to ensure interactivity throughout and make sure you’ll leave with actionable takeaways on model utility and applicability.

 

So, whether you’re looking to benchmark your model approach or are seeking to explore new systems and technologies, Tumour Models London offers you a unique opportunity to plug into a ready-made network of peers who continue to redefine this area and have already solved the variety of challenges you’re facing.

 

THE KEY QUESTIONS AT THE HEART OF THE TUMOUR MODELS SERIES:

 

1. What new model and related technology initiatives are helping biopharma leaders drive translational and early-stage decision making

 

2. How biopharma leaders are balancing the need for model complexity and relevance with time, throughput and cost

 

3. What are the key criteria the leading biotech and pharma use to assess, select and characterise the array of tumour models

 

 

URLs:

Brochure:  https://go.evvnt.com/276973-3?pid=3506

Booking: https://go.evvnt.com/276973-4?pid=3506

 

Speakers: Rajendra Kumari  General Manager and CSO  Crown Bioscience, Ralph Gareus  Director Business Development Europe  The Jackson Laboratories, Cristina Bertinetti-Lapatki  Principal Scientist, Investigative Safety  Roche, Dik C. van Gent  Associate Professor  Erasmus MC, Elizabeth Hardaker  Head, Oncology In Vivo Pharmacology Group  AstraZeneca, Fabien Garcon  Scientist I  MedImmune, Gavin Bennett  Head of Preclinical Development  Bicycle Therapeutics, Giorgio Seano  Head of Tumor Microenvironment Lab  Institut Curie Research Center, Jayesh Majithiya  Senior Scientist  Crescendo Biologics, Jean Viallet  CEO  Inovotion, Markus Reschke  Investigator III, Lab Head Oncology Research/Drug Discovery Pharmacology  Novartis, Marleen Van Loenen  Director – Non-Clinical Development  Gadeta, Maryland Franklin  Vice President – Scientific Development  MI Bioresearch, Anita Seshire  Head of Laboratory Cellular Pharmacology and Translational Innovation Platform Oncology  Merck KgGA, Ayako Pedersen  Head of Translational Research  IO Biotech APS, Anne Vaslin Chessex  Associate Director, Pharmacology and Screening  Debiopharm, Niina Veitonmäki  Director In Vivo Immune-Oncology  Molecular Partners AG, Alison Mackinnon  Preclinical Research Consultant  Galecto Biotech

Registration Info

Register Now

Admission :

Drug Developers Pricing: Conference + 2 Workshops: GBP 2999.0,

Drug Developers Pricing: Conference + 1 Workshop: GBP 2599.0,

Drug Developers Pricing: Conference Only: GBP 2199.0,

Model and Service Providers Pricing: Conference + 2 Workshops: GBP 3799.0,

Model and Service Providers Pricing: Conference + 1 Workshop: GBP 3299.0,

Model and Service Providers Pricing: Conference Only: GBP 2799.0

Organized by

Organized by LoveEvvnt1

Hanson Wade


Event Categories: Health & Nutrition.

Your Review

You must be logged in to post a comment.